Cite
HARVARD Citation
Gsottberger, F. et al. (n.d.). P03.20 A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment. Journal for immunotherapy of cancer. p. A30. [Online].